FibroScan® is the first non-invasive medical device that streamlines your management of chronic liver disease, from screening to follow-up and prognosis.
Reference solution providing patented dual function capability VCTE™ (fibrosis) and CAP™ (steatosis), the FibroScan® benefits from a worldwide clinical legitimacy and is recommended in the guidelines of leading organizations.
myFibroScan app is the best companion to enlarge the suite of diagnosis tools based on FibroScan® results:
- interpret FibroScan® examination results to assess fibrosis stage and steatosis grade, according to scientific publications, etiology and examination results VCTE™ and CAP™ with the Interpretation Guide tool
- assess the probability of active NASH with the new FAST™ score, combining FibroScan® biomarkers of liver fibrosis (VCTE™) and steatosis (CAP™) with blood biomarker of liver inflammation (AST). Best-in-class diagnostic performance and broad applicability demonstrated on 1,300 patients from different clinical setting and geographical origin: consistent 0.85-0.90 average AUROCs performance
Reference solution providing patented dual function capability VCTE™ (fibrosis) and CAP™ (steatosis), the FibroScan® benefits from a worldwide clinical legitimacy and is recommended in the guidelines of leading organizations.
myFibroScan app is the best companion to enlarge the suite of diagnosis tools based on FibroScan® results:
- interpret FibroScan® examination results to assess fibrosis stage and steatosis grade, according to scientific publications, etiology and examination results VCTE™ and CAP™ with the Interpretation Guide tool
- assess the probability of active NASH with the new FAST™ score, combining FibroScan® biomarkers of liver fibrosis (VCTE™) and steatosis (CAP™) with blood biomarker of liver inflammation (AST). Best-in-class diagnostic performance and broad applicability demonstrated on 1,300 patients from different clinical setting and geographical origin: consistent 0.85-0.90 average AUROCs performance
Read more
Collapse
What's New
Compliancy with latest Pubmed constraints, iOS 13 and Android 10 requirements
Read more
Collapse
Additional Information
Updated
October 1, 2020
Size
12M
Installs
5,000+
Current Version
2.1.16
Requires Android
5.1 and up
Content Rating
Everyone
Interactive Elements
Unrestricted Internet
Permissions
Report
Offered By
Liver-IT